Call Today for a FREE Confidential Case Review - Toll-Free 24/7 (866) 920-0753

FDA Approves Jardiance to Cut Risk of Cardiovascular Death

FDA Approves Jardiance to Cut Risk of Cardiovascular Death

December 6, 2016 — The FDA will allow Eli Lilly & Co. to market the diabetes drug Jardiance to reduce the risk of cardiovascular death, but questions remain about other safety risks.

Jardiance is the only diabetes drug that is approved to reduce the risk of death in adults with type-2 diabetes, which analysis say could boost sales by $1.7 billion.

Last year, a major clinical trial made headlines after showing that Jardiance cut the rate of cardiovascular death by 38% and reduced all-cause mortality by 32%. Diabetes patients have a 70% higher risk of cardiovascular death compared to people without diabetes, according to the CDC.

Jardiance belongs to a new generation of diabetes drugs known as SGLT2 inhibitors. They have only been on the market for a few years, but drug-makers are aggressively promoting them over older drugs.

The FDA has issued warnings about ketoacidosis (too much acid in the blood), a life-threatening side effect of Jardiance. It can occur even when blood-sugar levels are relatively normal. Symptoms include difficulty breathing, nausea, vomiting, abdominal pain, confusion, and unusual fatigue or sleepiness.

Jardiance reduces blood-sugar levels by forcing the kidneys to remove more sugar from the body in urine. Excessive urination can cause dehydration and low blood-pressure. More sugar in the urine also increases the risk of infections — the most common side effect.

Boehringer Ingelheim is facing a growing number of lawsuits from people who developed ketoacidosis after taking Jardiance. Lawyers are also investigating cases involving kidney failure, a side effect that has been linked to Invokana and other SGLT2 inhibitors.

Do I have a Jardiance Lawsuit?

The Schmidt Firm, PLLC is currently accepting Jardiance induced injury cases in all 50 states. If you or somebody you know has been diagnosed with ketoacidosis or kidney failure, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Free Case Evaluation

The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiffs’ law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firm’s reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.

*
*
*